Oliver Daltrop

Direttore Tecnico/Scientifico/R&S presso MOONLAKE IMMUNOTHERAPEUTICS

47 anni

Health Technology

Consumer Services

Posizioni attive di Oliver Daltrop

Società	Posizione	Inizio	Fine
MOONLAKE IMMUNOTHERAPEUTICS	Direttore Tecnico/Scientifico/R&S	01/09/2021	-
Moonlake Immunotherapeutics AG Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million.	Direttore Tecnico/Scientifico/R&S	01/09/2021	-

Società	Posizione	Inizio	Fine
Sandoz, Inc. Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ.	Corporate Officer/Principal	01/05/2020	01/08/2021

University of Bristol	Undergraduate Degree
University of Oxford	Doctorate Degree

Distribuzione geografica

Posizioni

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	1
Undergraduate Degree	1

Settori

Health Technology	4
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
MOONLAKE IMMUNOTHERAPEUTICS	Health Technology

Aziende private	2
Moonlake Immunotherapeutics AG Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million.	Health Technology
Sandoz, Inc. Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ.	Health Technology

Aziende private

Health Technology